You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 233 No. 11, September 15, 1975 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CLINICAL CARDIOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Practical Guidelines for the Use of Lidocaine

Prevention and Treatment of Cardiac Arrhythmias

Donald C. Harrison, MD

JAMA. 1975;233(11):1202-1204.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ALTHOUGH lidocaine hydrochloride was synthesized as a local anesthetic drug in 1943, its antiarrhythmic property was not recognized until the late 1950s, when anesthesiologists used the drug in the operating room for treating ventricular arrhythmias that occurred during the course of open heart surgery.1 In 1963, a detailed study2 reported the comparison of lidocaine with procainamide for treating intraoperative and postoperative ventricular arrhythmias in patients undergoing cardiac surgery. This study demonstrated that lidocaine was safe, highly effective, and preferable to procainamide for such arrhythmias.

With the development of the coronary care unit during the 1960s, lidocaine was found to be an important agent in controlling life-threatening arrhythmias,3 and in 1967, its use for the treatment of less serious ventricular rhythm disturbances, which frequently herald the development of life-threatening arrhythmias, was proposed.4 Subsequently, it gained general acceptance in the coronary care unit for both treating and preventing . . . [Full Text PDF of this Article]


Author Affiliations

From the Cardiology Division, Stanford University School of Medicine, Stanford, Calif. Dr. Harrison is the William G. Irwin Professor of Medicine.


Footnotes

Reprint requests to Cardiology Division, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305 (Dr. Harrison).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.